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Summary.-We have evaluated the relation between cancer of the lower urinary tract
("bladder cancer") and the use of artificial sweeteners, by means of case-control
studies in Manchester, U.K., and Nagoya, Japan, areas where extensive use occurred
30-40 years ago. In each area, a broadly based series of cases (555 in Manchester,
293 in Nagoya) was interviewed and a series of controls (735 in Manchester, 589
in Nagoya) chosen from the general population. A history of use of sugar substitutes
primarily saccharin, was not associated with an elevated risk of bladder cancer in
either study area. Risk of bladder cancer did not increase regularly with frequency
or duration of use of sugar substitutes. Data on dietetic beverages were not obtained
in Nagoya. This exposure was not associated with a greater risk of bladder cancer
in Manchester. The results of this study suggest that use of artificial sweeteners
confers little or no risk of bladder cancer.
THIS IS A REPORT of a collaborative
case-control study ofenvironmental causes
of cancer of the lower urinary tract
("bladder cancer") in Manchester, U.K.,
Nagoya, Japan, and Boston, Massa-
chusetts, U.S.A. The purpose ofthis paper
is to present data on the relation between
the development ofbladder cancer and the
use of artificial sweeteners. Most previous
information on this question has come
from the United States, including a
report from the Boston centre of the
present study (Morrison & Buring, 1980).
In the United States, most use of artificial
sweeteners has occurred fairly recently,
and both saccharin and cyclamates have
been used widely. Here we focus on
artificial sweeteners and bladder cancer
in the United Kingdom and Japan,
areas where saccharin has been used
primarily, and where extensive use occur-
red 30-40 years ago.
METHODS
The study was done in 3 areas: Greater
Boston, Massachusetts, U.S.A., part of
Greater Manchester County, U.K., and
metropolitan Nagoya, Japan. The study
methods have been described in detail
(Morrison & Buring, 1980; Morrison et al.,
1982.) Briefly, an attempt was made to
assemble a complete series of incident cases
in each area during the respective study
period (October, 1976 to September, 1978,
in Manchester; January, 1976 to December,
1978, in Nagoya). Case identification was
accomplished primarily through hospitals.
To be eligible a case had to have an initial
diagnosis of a primary neoplasm of the lower
urinary tract (bladder, ureter, renal pelvis,
urethra) during the study period, and to be
at least 21 years old and a resident of the
study area at the time of diagnosis. Cases
over 89 years old at the time of diagnosis
were not eligible for interview. Tumours
throughout the histological spectrum from
papilloma to invasiveneoplasia wereincluded.SWEETENERS AND BLADDER CANCER
For brevity, the term "bladder cancer" is
used for neoplasms of the lower urinary
tract (Morrison & Buring, 1980).
Controls were selected from electoral
registers available in each study area. The
sampling methods ensured that each control
series had an age and sex distribution similar
to that of the respective series of cases.
There were 577 cases and 817 controls
selected in Manchester, and 348 cases and
735 controls selected in Nagoya. The control:
case ratio of 1P4: 1 in Manchester was some-
what larger than the ratio of 1 :1 that
was originally planned. The difference was a
consequence of the two-stage sampling
procedure that was used to select controls in
that area (Morrison, et al., 1982). In Nagoya
about twice as many controls were selected as
there were cases, because the number of cases
available for studythere was relatively small.
Subjects were interviewed according to a
standardized schedule. If a subject was too
ill for interview, could not be contacted, or
had died, an attempt was made to interview
a proxy-a relative or friend familiar with
the subject's background and habits. In
Manchester, most interviews were carried out
at subjects' homes. In Nagoya, most controls
were interviewed at home, but most cases
were interviewed as in-patients or during
out-patients visits (Morrison et al., 1982).
Interviews were obtained for 555 cases
(96% of the total eligible) and 735 controls
(90%o) in Manchester, and 293 cases (84%)
and 589 controls (80%) in Nagoya.
The interview included questions on many
known or suspected causes of bladder cancer
(Morrison & Buring, 1980). Questions on
"current" exposures referred to the year
before interview, or to the calendar year
before hospitalization for cases interviewed
more than a year after initial admission.
Any reported use of artificial sweeteners
after these times was ignored in the present
analysis.
With respect to use of artificial sweeteners,
subjects in Manchester were asked, first,
whether they had used "diet or low-calorie
beverages", several examples of which were
named by the interviewers. Users were asked
the average frequency of consumption during
the period of use, when use began, the period
of maximum frequency and what the maxi-
mum frequency had been, the current
frequency, and the time of discontinuation
of use, if applicable. Subjects were also asked
if they had used "any sweetener other than
sugar". Those who had were asked when use
began and the reason for use, whether they
had ever used saccharin and when use of that
substance began, whether sugar substitutes
were used currently and, ifso, the usual brand
of sugar substitute used, and the current
amounts and frequencies of use of sugar
substitutes in beverages and foods. If sugar
substitutes were no longer used, the time of
discontinuation was asked. Finally, subjects
were asked their current frequencies of use of
'low-calorie or low-sugar brands" of various
foods.
In Japan it is not generally possible to
determine from product labels whether
prepared foods contain artificial sweeteners.
Therefore. Nagoya subjects were not ques-
tioned on their use of dietetic beverages and
foods. However, they were asked about their
use of sugar substitutes added to beverages
and foods. These questions corresponded to
those asked of the Manchester subjects.
Thirteen interviews from Manchester (6
cases and 7 controls) and 16 from Nagoya
(3 cases and 13 controls) were excluded from
the present analysis because there was
insufficient information for adequate classi-
fication of their histories of use of artificial
sweeteners. Additional subjects were excluded
from individual comparisons because of
inadequate response to specific questionnaire
items.
Results are expressed in terms of the
"relative risk" (RR), the ratio of the bladder
cancer incidence rate of exposed to that of
unexposed persons. Unexposed subjects in
Manchester were defined as those who re-
ported never using dietetic beverages or sugar
substitutes and no current use of artificially
sweetened foods. Unexposed subjects in
Nagoya were defined as those who reported
never using sugar substitutes. Relative
risks presented are simultaneous maximum-
likelihood estimates (Bishop et al., 1975; Gart,
1970) with stratification for age ( < 65, 65-74,
75+) and, when indicated in the context,
sex or smoking history. Pre iminary analysis
indicated that control of occupational history
(in men) had little effect on our results.
Therefore, occupational history has not been
controlled in this presentation.
RESULTS
Sugar substitutes
Subjects who had used sugar substitutes
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TABLE I.-Numbers of cases and controls and relative risk (RR) according to a history of
use of sugar substitutes, by area and sex
Men
Sugar , M--
Area substitutes Cases Controls RR CI*
Manchester Used 140 183 0 9 (0-7-12)
No exposure 242 287 1
Nagoya Used 100 238 0 7 (0 5-0 9)
No exposure 123 194 1
* 95% confidence interval.
did not appear to have a greater risk of
bladder cancer (Table I). In Nagoya
there was a moderate inverse association
of sugar substitutes and bladder cancer.
This association was not explained by
case-control differences in date of inter-
view, interviewer, place of birth, or
amount of education. The proportion of
cases that had used artificial sweeteners
was Lnot related consistently to place
of interview or to the time between
diagnosis and interview.
Of the subjects who reported use of
sugar substitutes, 97% in Manchester and
94% in Nagoya reported that they had
used saccharin (though not necessarily
exclusively). Most subjects in Nagoya,
and many in Manchester who had used
sugar substitutes, first used them during
or shortly after World War II. In Man-
chester there were 161 men and 48 women
who began using artificial sweeteners
30-39 years before interview. The cor-
responding relative risks (RR) were 0 9
(0.6-1.3, 95% confidence interval) and
0-8 (0.4-1.5). In Nagoya 303 men and
99 women reported that they began using
artificial sweeteners 30-39 years before
interview. The RRs for these subjects
were 0-6 (0.4-0.8) and 0-4 (0-2-0.8),
Women
Cases Controls RR CI*
50 87 0 9 (0*6-1*4)
92 133 1
26 83 0-5 (0 3-0 8)
40 61 1
respectively. In both study areas only a
minority of exposed subjects were current
users of artificial sweeteners (92 men and
54 women in Manchester; 17 men and
7 women in Nagoya). Because ofthe small
numbers of subjects, an analysis of risk
of bladder cancer in relation to current
frequency of use in Nagoya is not pre-
sented. Current frequency of use of sugar
substitutes in tablet form did not show
a regular relationship to risk for either men
or women in Manchester (Table II).
All men who had used tablets had RR < 1,
while heavy users among women had an
RR > 1. There were too few users of sugar
substitutes in powdered form (10 men,
4 women) or liquid form (1 man, 4
women) for satisfactory analysis.
Increasing duration of use of sugar
substitutes was not associated with a
consistent increase in risk of bladder
cancer in either Manchester or Nagoya
(Table III).
Dietetic beverages andfoods
As indicated above, data on these
exposures were collected only in Man-
chester. A history ofuse ofdietetic bevera-
ges was reported by a much smaller
number of subjects than was a history
TABLE II.-Numbers of cases and controls and RR according to currentfrequency of use
ofsugar substitutes in tabletform in Manchester, by sex
Men
Cases Controls RR
10 19 0-6
17 20 0-8
12 14 0-8
242 287 1
Women
Cases Controls RR
9 8 2*3
4 12 0-6
7 14 0 7
92 133 1
Frequency
(tablets/day)
10+
5-9
<5
No exposure
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TABLE III.-Numbers of cases and controls and RR according to duration of use of sugar
substitutes, by area and sex
Duration
Area (yrs)
Manchester 15+
9-14
6-8
3-5
<3
No exposure
Nagoya 9+
6-8
3-5
<3
No exposure
Men
Cases Controls RR
12
5
43
38
34
242
6
6
24
41
123
18
12
32
51
57
287
20
13
48
108
194
0 9
0 3
1*6
0 9
0 7
1
0 5
0 7
0-8
0-6
1
Women
A
Cases Controls RR
5 13 0 9
5 9 04
12 14 1-2
8 24 0 5
18 24 1-3
92 133 1
}
3
8
13
40
7
22
48
61
0*6
0 5
0 4
1
of use of sugar substitutes. Among men,
25 cases and 33 controls were so exposed;
the RR was estimated as 0'9 (0.5-1.6).
Among women, 14 cases and 27 controls
had used dietetic beverages; the RR
was estimated as 0'9 (0.4-1.8). Because
of the small number of exposed subjects,
data on frequency and duration of use
are not presented.
There were 25 men and 35 women who
were current consumers of dietetic foods.
The RRs were estimated as 1 0 (0.4-2-1)
in men and 1I3 (0 6-2 8) in women.
Relation to cigarette smoking
Cigarette smoking was associated with
risk of bladder cancer in both Manchester
and Nayoga. Data on use of sugar sub-
stitutes are given according to cigarette-
smoking history in Table IV. In Man-
chester, the RR associated with use of
sugar substitutes was highest in non-
smokers of both sexes, but these increases
were small. In the sexes combined, the
estimate of RR with control of age, sex,
and smoking history was 1 0. In Nagoya,
the RRs associated with use of sugar
substitutes were< 1 in all smoking cate-
gories. With adjustment for age, sex
and smoking history, the RR was 0-6.
DISCUSSION
Many epidemiological studies on the
relation of the use of artificial sweeteners
to the development of bladder cancer
have been reported previously and their
methods and results have been reviewed
(Cartwright et al., 1981; Committee for a
Study on Saccharin and Food Safety
Policy, 1978; Morrison & Buring, 1980).
TABLE IV.-Numbers of cases and controls according to history of use of sugar substitutes,
and RRfor users, by cigarette smoking, area and sex
Area
Manchester
Nonsmoker
Current smoker
Ex-smoker
Summary
Men
Cases* Controls* RR
11; 19
70; 141
59; 82
140; 242
22; 46
73; 135
88; 105
183; 286
1-6
0 9
0 9
0 9t
(0- 7-1 - 3)
Women
Cases* Controls* RR
24;
18;
8;
50;
39
42
11
92
44;
23;
20;
87;
58
47
28
133
1-2
0 9
1.0
1- it
Nagoya
Nonsmoker 9; 15 41; 35 0 5 16; 28 76; 53 0 4
Current smoker 80; 91 149; 118 0 7 8; 11 6; 7 0-8
Ex-smoker 11; 17 48; 41 0-6 2; 1 1; 1
Summary 100; 123 283; 194 0 7t 26; 40 83; 61 0 5t
(0.5-0 9) (0.2-0-9)
* Number of exposed subjects followed by number of unexposed subjects.
t Estimates with stratification for age and smoking history; 95% confidence intervals in brackets.
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Taken together, these studies suggest
that use of artificial sweeteners is not an
important risk factor for bladder cancer.
Generally, the observed RRs have been
-W 1, and weak inverse associations have
been observed about as often as weak
direct ones. The results of the present
study are consistent with the previous
findings. Overall, use of artificial sweet-
eners was not associated with increased
risk of bladder cancer, nor did risk appear
to increase regularly with increasing
frequency or duration of use of artificial
sweeteners. However, it should be noted
that a weak carcinogenic effect would be
difficult to detect. Furthermore, a true
association could be obscured by inac-
curacies in the exposure histories.
In two studies in England-ours and a
recent one reported by Cartwright et al.
(1981)-the RR of bladder cancer associa-
ted with use of artificial sweeteners was
highest among male non-smokers. How-
ever, thisfinding is notgenerally consistent
with studies in the United States (Mor-
rison & Buring, 1980; Hoover et al., 1979;
Hoover & Strasser, 1980) and Canada
(Howe et al., 1977; Miller & Howe, 1977),
nor with the present results from Japan.
Most previous studies of artificial sweet-
eners and bladder cancer were carried
out in the United States, where both
saccharin and cyclamate have been used
extensively. Consequently, it has been
difficult to separate the effects of these
two sweeteners. However, our findings
and those of Cartwright et al., (1981)
bear primarily on the use ofsaccharin.
A high proportion of subjects in both
areas in the present study used saccharin
in the years during and immediately
after World War II. Thus the study
provides some information on the long-
term effects of saccharin. Positive associa-
tions of artificial sweeteners and bladder
cancer were not found after an "induction
period" of 30 years or more. However,
this result should be interpreted cautiously
The intense use was for only a few years,
perhaps not long enough to have had a
detectable effect on rate of bladder cancer.
An inverse relation was observed be-
tween artificial sweeteners and bladder
cancer in Nagoya. This association was
not explained by several potential con-
founding factors, or by factors related to
interview quality. It seems most likely
that the observed inverse association is
the result of either random variability
or an unrecognized bias.
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